Literature DB >> 18078560

Is NESTROFT sufficient for mass screening for beta-thalassaemia trait?

Manju Mamtani1, Kishalaya Das, Anil Jawahirani, Vinky Rughwani, Hemant Kulkarni.   

Abstract

OBJECTIVES: Prevention of beta-thalassaemia trait will, for the foreseeable future, hinge on effective screening strategies. Routine use of haematological data from automated cell counters may complement the results of the Naked Eye Single Tube Red cell Osmotic Fragility Test (NESTROFT), especially because of the high cost of a false-negative error. Our objective was to assess the potential additive value of routine haematological data in screening for beta-thalassaemia trait. SETTINGS: Community survey of asymptomatic volunteers.
METHODS: Using the NESTROFT results, haematological data and haemoglobin A(2) concentration from 1435 young, asymptomatic Sindhi subjects recruited in a population-based survey, and statistical analysis by classification tree approach, we examined whether haematological parameters have discriminatory utility additional to that of NESTROFT in screening for beta-thalassaemia trait.
RESULTS: We observed that in the derivation subset from which the classification tree was generated, there was only a marginal--albeit statistically significant--improvement in the screening performance of NESTROFT, whereas there was no such improvement attributable to the use of haematological parameters in a separate validation subset.
CONCLUSION: Our results further substantiate the claim that the use of NESTROFT is highly indicated for screening for beta-thalassaemia trait in regions where the prevalence is high and the resources are constrained.

Mesh:

Year:  2007        PMID: 18078560     DOI: 10.1258/096914107782912086

Source DB:  PubMed          Journal:  J Med Screen        ISSN: 0969-1413            Impact factor:   2.136


  5 in total

1.  NESTROFT - A Valuable, Cost Effective Screening Test for Beta Thalassemia Trait in North Indian Punjabi Population.

Authors:  Sanjay Piplani; Rahul Manan; Monika Lalit; Mridu Manjari; Tajinder Bhasin; Jasmine Bawa
Journal:  J Clin Diagn Res       Date:  2013-11-20

2.  Screening for beta thalassaemia.

Authors:  Mary Petrou
Journal:  Indian J Hum Genet       Date:  2010-01

Review 3.  Past, present & future scenario of thalassaemic care & control in India.

Authors:  Ishwar C Verma; Renu Saxena; Sudha Kohli
Journal:  Indian J Med Res       Date:  2011-10       Impact factor: 2.375

Review 4.  Epistasis and the sensitivity of phenotypic screens for beta thalassaemia.

Authors:  Bridget S Penman; Sunetra Gupta; David J Weatherall
Journal:  Br J Haematol       Date:  2014-12-17       Impact factor: 6.998

5.  NESTROFT-A Cost-Effective Mass Screening Tool for the Detection of β-Thalassemia Carrier Status in Anemic Pregnant Women: A Step Toward Reducing the National Disease Burden.

Authors:  Manasi Gosavi; Ramesh Chavan; M B Bellad
Journal:  J Lab Physicians       Date:  2021-07-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.